Search Results - "Walker, Bruce D"

Refine Results
  1. 1

    HIV and HLA Class I: An Evolving Relationship by Goulder, Philip J.R., Walker, Bruce D.

    Published in Immunity (Cambridge, Mass.) (21-09-2012)
    “…Successful vaccine development for infectious diseases has largely been achieved in settings where natural immunity to the pathogen results in clearance in at…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design by Ferguson, Andrew L., Mann, Jaclyn K., Omarjee, Saleha, Ndung’u, Thumbi, Walker, Bruce D., Chakraborty, Arup K.

    Published in Immunity (Cambridge, Mass.) (21-03-2013)
    “…A prophylactic or therapeutic vaccine offers the best hope to curb the HIV-AIDS epidemic gripping sub-Saharan Africa, but it remains elusive. A major challenge…”
    Get full text
    Journal Article
  4. 4

    Toward an AIDS Vaccine by Walker, Bruce D, Burton, Dennis R

    “…A quarter century of scientific discovery has been applied to developing an AIDS vaccine, yet this goal remains elusive. Specific characteristics of the virus,…”
    Get full text
    Journal Article
  5. 5

    PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention by Kaufmann, Daniel E, Walker, Bruce D

    Published in The Journal of immunology (1950) (15-05-2009)
    “…The balance between proinflammatory mechanisms and the dampening of excessive immune activation is critical for successful clearance of a pathogen without harm…”
    Get full text
    Journal Article
  6. 6

    Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control by Ackerman, Margaret E, Mikhailova, Anastassia, Brown, Eric P, Dowell, Karen G, Walker, Bruce D, Bailey-Kellogg, Chris, Suscovich, Todd J, Alter, Galit

    Published in PLoS pathogens (01-01-2016)
    “…Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    The fitness landscape of HIV-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing by Mann, Jaclyn K, Barton, John P, Ferguson, Andrew L, Omarjee, Saleha, Walker, Bruce D, Chakraborty, Arup, Ndung'u, Thumbi

    Published in PLoS computational biology (01-08-2014)
    “…Viral immune evasion by sequence variation is a major hindrance to HIV-1 vaccine design. To address this challenge, our group has developed a computational…”
    Get full text
    Journal Article
  10. 10

    Immunogenetics of Spontaneous Control of HIV by Carrington, Mary, Walker, Bruce D

    Published in Annual review of medicine (01-01-2012)
    “…Host genetic variation is presently estimated to account for about one-fourth of the observed differences in control of HIV across infected individuals…”
    Get full text
    Journal Article
  11. 11

    Accelerating Next-Generation Vaccine Development for Global Disease Prevention by Koff, Wayne C., Burton, Dennis R., Johnson, Philip R., Walker, Bruce D., King, Charles R., Nabel, Gary J., Ahmed, Rafi, Bhan, Maharaj K., Plotkin, Stanley A.

    “…Vaccines are among the greatest successes in the history of public health. However, past strategies for vaccine development are unlikely to succeed in the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable by Barton, John P., Goonetilleke, Nilu, Butler, Thomas C., Walker, Bruce D., McMichael, Andrew J., Chakraborty, Arup K.

    Published in Nature communications (23-05-2016)
    “…Human immunodeficiency virus (HIV) evolves within infected persons to escape being destroyed by the host immune system, thereby preventing effective immune…”
    Get full text
    Journal Article
  14. 14

    Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes by Jones, Richard Brad, O'Connor, Rachel, Mueller, Stefanie, Foley, Maria, Szeto, Gregory L, Karel, Dan, Lichterfeld, Mathias, Kovacs, Colin, Ostrowski, Mario A, Trocha, Alicja, Irvine, Darrell J, Walker, Bruce D

    Published in PLoS pathogens (01-08-2014)
    “…Resting memory CD4+ T-cells harboring latent HIV proviruses represent a critical barrier to viral eradication. Histone deacetylase inhibitors (HDACis), such as…”
    Get full text
    Journal Article
  15. 15
  16. 16

    HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses by Clayton, Kiera L., Mylvaganam, Geetha, Villasmil-Ocando, Alonso, Stuart, Heather, Maus, Marcela V., Rashidian, Mohammad, Ploegh, Hidde L., Walker, Bruce D.

    Published in Cell host & microbe (10-03-2021)
    “…Natural killer (NK) cells are innate cytolytic effectors that target HIV-infected CD4+ T cells. In conjunction with antibodies recognizing the HIV envelope, NK…”
    Get full text
    Journal Article
  17. 17

    Reactivation of Latent HIV-1 by Inhibition of BRD4 by Zhu, Jian, Gaiha, Gaurav D., John, Sinu P., Pertel, Thomas, Chin, Christopher R., Gao, Geng, Qu, Hongjing, Walker, Bruce D., Elledge, Stephen J., Brass, Abraham L.

    Published in Cell reports (Cambridge) (25-10-2012)
    “…HIV-1 depends on many host factors for propagation. Other host factors, however, antagonize HIV-1 and may have profound effects on viral activation. Curing…”
    Get full text
    Journal Article
  18. 18

    HIV-1 DNA sequence diversity and evolution during acute subtype C infection by Lee, Guinevere Q., Reddy, Kavidha, Einkauf, Kevin B., Gounder, Kamini, Chevalier, Joshua M., Dong, Krista L., Walker, Bruce D., Yu, Xu G., Ndung’u, Thumbi, Lichterfeld, Mathias

    Published in Nature communications (21-06-2019)
    “…Little is known about the genotypic make-up of HIV-1 DNA genomes during the earliest stages of HIV-1 infection. Here, we use near-full-length, single genome…”
    Get full text
    Journal Article
  19. 19

    Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination by Mahan, Alison E, Jennewein, Madeleine F, Suscovich, Todd, Dionne, Kendall, Tedesco, Jacquelynne, Chung, Amy W, Streeck, Hendrik, Pau, Maria, Schuitemaker, Hanneke, Francis, Don, Fast, Patricia, Laufer, Dagna, Walker, Bruce D, Baden, Lindsey, Barouch, Dan H, Alter, Galit

    Published in PLoS pathogens (01-03-2016)
    “…Antibody effector functions, such as antibody-dependent cellular cytotoxicity, complement deposition, and antibody-dependent phagocytosis, play a critical role…”
    Get full text
    Journal Article
  20. 20

    Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology by Mylvaganam, Geetha, Yanez, Adrienne G, Maus, Marcela, Walker, Bruce D

    Published in Frontiers in immunology (10-09-2019)
    “…As the AIDS epidemic unfolded, the appearance of opportunistic infections in at-risk persons provided clues to the underlying problem: a dramatic defect in…”
    Get full text
    Journal Article